On August 6, YUKIGUNI FACTORY CO., LTD. (hereinafter, the Company) announced its consolidated financial results for Q1 FY2027/3.
For Q1, revenue reached a record high and core EBITDA substantially exceeded the same period last year.
If the Company’s ability to sustainably generate ROE above 20% is reflected in the results toward the final year of the Mid-term Business Plan, and if expectations of a transformation into a life-science IP company take hold, SIR believes there is considerable scope for the equity to be re-rated by the market.
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.